Serotonergic tryptamines, also known as “classical psychedelics,” such as Psilocybin, DMT, and LSD, are primarily known for their psychedelic effects. However, there is growing interest in their potential therapeutic applications, including their anti-inflammatory properties and use in the treatment of autoimmune disorders such as Celiac disease, Rheumatoid arthritis, Hashimoto Thyroiditis, and even Type 1 diabetes. Both microdosing and macrodosing effects the immune system and inflammation.

 

Anti-Inflammatory Properties of Classical Psychedelics

Serotonin Receptors and Inflammation

Classical psychedelics primarily interact with serotonin receptors, particularly the 5-HT2A receptor, which is known to play a role in modulating the immune response and inflammation. Research suggests that psychedelics like LSD may influence immune responses by activating 5-HT2A receptors, which can lead to a reduction in pro-inflammatory cytokines, the signaling molecules responsible for triggering and maintaining inflammation.

Neuroinflammation

Evidence suggests that classical psychedelics may reduce inflammation and neuroinflammation, which is inflammation within the central nervous system, which is a key factor in neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease. In animal studies, psychedelics like LSD have shown potential to reduce markers of neuroinflammation, making them promising for conditions characterized by chronic brain inflammation.

Modulation of Cytokine Activity

Cytokines are key regulators of the immune response, signaling proteins that can either promote or inhibit inflammation. Pro-inflammatory cytokines such as TNF-α and IL-6 are often elevated in chronic inflammatory diseases, while anti-inflammatory cytokines like IL-10 help to reduce inflammation. Research indicates that classical psychedelics may shift this balance, reducing the levels of pro-inflammatory cytokines and increasing the production of anti-inflammatory ones. This shift could be beneficial in treating chronic inflammatory and autoimmune conditions, where the immune system mistakenly attacks healthy tissues (source).

There is a well-established connection between stress and inflammation. Chronic stress can exacerbate immune dysregulation, leading to increased inflammation. Psychedelics, through their profound effects on perception and mood, may help reduce stress, thereby indirectly lowering inflammatory responses in the body. While this psychosomatic link remains speculative, early studies support the role of stress reduction in the anti-inflammatory effects of psychedelics.

Immune Response Modulation via 5-HT2A Interaction

Classical psychedelics modulate the immune response primarily through their interaction with the 5-HT2A receptor, which is present not only in neurons but also on various immune cells, such as macrophages, T-cells, and dendritic cells. Activation of these receptors by psychedelics can influence the behavior of immune cells, potentially reducing inflammatory responses and promoting a more balanced immune function.

Effects on Macrophages

Macrophages are immune cells responsible for detecting and destroying pathogens. Activation of the 5-HT2A receptor on macrophages has been shown to alter their cytokine release patterns, reducing the secretion of pro-inflammatory cytokines like TNF-α and IL-6, which are commonly elevated in autoimmune diseases (source).

Effects on T Cells

T cells play a critical role in managing the balance between pro-inflammatory (Th1) and anti-inflammatory (Th2) responses. By altering T cell differentiation and function, classical psychedelics may shift the immune response towards an anti-inflammatory state, reducing chronic inflammation and potentially aiding in the treatment of autoimmune disorders (source).

Neuroinflammation and Chronic Pain

The effects of classical psychedelics on 5-HT2A receptors in the brain may also help reduce neuroinflammation, which is associated with neurodegenerative diseases and chronic pain conditions. Modulation of microglia (immune cells in the brain) via 5-HT2A receptor activation could dampen the inflammatory response, alleviating symptoms related to neurodegeneration and chronic pain.

The Psychedelic Experience and Immune Modulation

The psychedelic experience itself, induced by classical psychedelics through 5-HT2A receptor activation, may also contribute to stress reduction, which is closely linked to decreased inflammation. By shifting perception and reducing emotional stress, classical psychedelics may indirectly lower immune activation caused by chronic stress.

Modulating the Default Mode Network (DMN)

Classical psychedelics also disrupt the default mode network (DMN), a set of brain regions involved in self-referential thinking and rumination. Research suggests that this disruption may help reduce chronic, stress-related inflammation by changing how the brain processes emotions, stress, and trauma—factors linked to immune dysregulation.

 

Trauma as a Root Source of Autoimmune disorders

Research increasingly supports a link between Autoimmune disorders and trauma, particularly chronic or early-life trauma, and the development of autoimmune disorders. This connection centers on how trauma affects the immune system and stress response, potentially leading to autoimmune issues.

Conclusion

By interacting with the 5-HT2A receptor, classical psychedelics influence the balance of pro- and anti-inflammatory responses in the body. This modulation occurs through both direct effects on immune cells and indirect effects related to stress reduction and neuroinflammation. While the findings are promising, much of the research is still at the preclinical stage, and more studies are needed to clarify how these effects can be harnessed therapeutically for autoimmune disorders and other chronic inflammatory conditions.